Health
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health
SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced it has signed two strategic memoranda of understanding (MoUs) with NEOM, the sustainable region under development in northw...
2025-10-28 17:00
1419
Xinhua Silk Road: Innovation, tradition deeply integrated on TCM trade fair in China's Zhangshu City
BEIJING, Oct. 28, 2025 /PRNewswire/ -- China's Zhangshu City, a famed
industrial hub of traditional Chinese medicine (TCM) for centuries, has
actively promoted integration of tradition and innovation forChina's
traditional medicines and medical treatment on its annual TCM fair.
2025-10-28 16:31
832
Samsung Biologics reports third quarter 2025 financial results
* Recorded Q3'25 consolidated revenue of KRW 1,660.2 billion * Recorded Q3'25 consolidated operating profit of KRW 728.8 billion * Delivered consistent performance through stable capacity ramp-up and strengthened global partnerships INCHEON, South Korea, Oct. 28, 2025 /PRNewswire/ -- Samsung...
2025-10-28 14:50
1242
Xinhua Silk Road: Traditional Chinese medicine showcases its timeless magic
BEIJING, Oct. 28, 2025 /PRNewswire/ -- Under the night sky, Yongde Road Pedestrian Street is exceptionally bustling, where a vibrant Traditional Chinese Medicine (TCM) night market is unfolding. Niladri, an international student fromBangladesh studying at Shanghai Jiao Tong University, had an im...
2025-10-28 11:38
671
Standard Foods Announces Strategic Partnership and Investment in Hello Health to Strengthen the Bridge Between Digital Health and Nutrition in Southeast Asia.
SINGAPORE, Oct. 28, 2025 /PRNewswire/ -- Hello Health Group (HHG), Asia's leading digital health and wellness platform, andStandard Foods Group (SFG), a leading nutrition and health-related consumer goods company headquartered in Taiwan, are pleased to announce a strategic partnership, with SFG jo...
2025-10-28 10:00
1025
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Fast Track Designation by FDA for the Treatment of PROC
SUZHOU, China, Oct. 28, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of advanced or...
2025-10-28 09:46
923
JSBio Strengthens Commitment to Power Cellular Agriculture Commercialization
Building on biopharma expertise, JSBio drives scalable innovation and partnerships to advance the cellular agriculture industry. SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- JSBio, a leading cell culture media manufacturer and service provider in the APAC region, is deepening its commitment to cellu...
2025-10-28 09:00
1025
Onward Therapeutics Exercises Exclusive Option and Signs Worldwide License Agreement with Institut du Cancer de Montpellier for Novel Onco-Metabolism Program
EPALINGES, Switzerland, Oct. 28, 2025 /PRNewswire/ -- Onward Therapeutics SA, a clinical stage oncology company, today announced that its French subsidiary, Onward Therapeutics France, has exercised its exclusive option and entered into a worldwide license agreement with Institut du Cancer de Mon...
2025-10-28 08:00
816
Nippon Shinyaku Selects LifeSphere® Safety
Japan-based Nippon Shinyaku has chosen LifeSphere MultiVigilance as new case
processing database
TOKYO, Oct. 28, 2025 /PRNewswire/ -- ArisGlobal
2025-10-28 07:00
1088
Vietnam Healthcare Summit 2025: Powering Transformation of Vietnam's Healthcare Landscape Through Innovation and Investment
HO CHI MINH CITY, Vietnam, Oct. 28, 2025 /PRNewswire/ -- Vietnam Innovators Digest successfully hosted the Vietnam Healthcare Summit 2025 under the theme "Making Vietnam an Innovation Hub Through Healthcare", held at JW Marriott Hotel & Suites Saigon. The event gathered over200 healthcare leaders...
2025-10-28 01:31
1351
Fibronostics Acquires Stone Clinical Laboratories to Advance MASH/MASLD Diagnostics
Acquisition expands U.S. lab operations and accelerates innovation in non-invasive diagnostics for metabolic and liver diseases. NEW ORLEANS, Oct. 27, 2025 /PRNewswire/ -- Fibronostics, a global leader in non-invasive diagnostics for metabolic and liver diseases, today announced the completion o...
2025-10-27 22:46
983
The WEMP Foundation and Rafa Nadal Foundation are joining together to Support Total Wellbeing of Children and Youth through Play
HONG KONG, Oct. 27, 2025 /PRNewswire/ -- The WEMP Foundation (WEMP, which stands for "Wellbeing", "EQ", "Mental Health", and "Parenting") and theRafal Nadal Foundation (RNF) are delighted to announce their alliance for supporting total wellbeingof children and youth around the world through Play....
2025-10-27 22:13
1176
Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., Oct. 27, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech developing a novel treatment for gout, today announced the successful completion o...
2025-10-27 21:00
845
Kolmar Korea Selected for Government-Led 'AI Factory' Initiative -- Driving Innovation in K-Beauty Manufacturing
* The only cosmetics company chosen by the Ministry of Trade, Industry and
Resources for the "AI Factory" project
* Enables agile, small-batch, multi-product production to meet diverse client
needs in real time SEOUL, South Korea, Oct. 27, 2025 /PRNewswire/ -- Kolmar
Korea
2025-10-27 20:30
4027
BioDlink Completes First International Shipment of Bevacizumab to Colombia
* Bevacizumab is a targeted therapy used to treat lung and colorectal cancers, both among the top three cancers ranked by death inColombia[1]. * This inaugural shipment—dispatched around two months after Colombia's marketing approval—demonstrates the company's efficiency, while validating its ...
2025-10-27 20:30
946
National Center of Technology Innovation for Dairy Debuts at the IDF World Dairy Summit, Showcasing Innovation to Drive Sustainability
SANTIAGO, Chile, Oct. 27, 2025 /PRNewswire/ -- The highly anticipated 2025 IDF World Dairy Summit took place fromOctober 20 to 23 in Santiago, Chile. Drawing global attention, the event served as an important barometer for the future of the dairy industry. Liu Chunxi, Chairman of the National Ce...
2025-10-27 19:23
1051
Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner
SYDNEY, Oct. 27, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") today announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug Administration (FDA) to discuss overall survival (OS) findings in newly diagnosed glioblastoma (GBM) p...
2025-10-27 19:15
1763
China's NMPA Grants Breakthrough Therapy Designation for Anti-CTLA-4 Antibody Candidate Gotistobart (BNT316/ONC-392)
Designation granted for gotistobart (BNT316/ONC392) for the treatment of patients with squamous non-small cell lung cancer (sqNSCLC), an aggressive subtype of lung cancer Breakthrough Therapy designation will allow for an expedited development and regulatory review of gotistobart inChina Globa...
2025-10-27 19:00
949
Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial
* Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study * 94 patients enrolled out of 102 planned across Korea and the U.S. * Interim baseline characteristics to be presented at the 2025 KATRD International Conference SEOUL, South Korea, Oct...
2025-10-27 19:00
1004
Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025
-Multiple posters being presented on Ascletis' small molecule and peptide obesity programs -Full analysis of 28-day multiple ascending dose study of oral GLP-1R small molecule agonist ASC30 as a late-breaking poster as well as ASC30 once-monthly treatment formulation and once-quarterly maintenan...
2025-10-27 18:00
1164
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 285 media titles]
2025-12-10 16:00
Asia Pacific Defies Global Headwinds: Mastercard Economics Institute 2026 Outlook
[Picked up by 275 media titles]
2025-12-10 09:00